Switzerland's Lonza, one of the leading contract manufacturers of
active pharmaceutical ingredients, has forged a collaboration with
RNA-TEC of Belgium to provide broad-ranging contract production of
oligonucleotides, a new class...
Swiss life science company Lonza, that earlier this week announced
imminent cutbacks and job losses, has settled a patent infringement
action with Nutrition 21, a US company that currently holds 22
patents for chromium compounds.
Speciality chemicals company International Specialty Products (ISP)
continues its quest to expand the company's presence in the growing
personal care market segment with the news this week that it has
collaborated with biotech...
UK-based vaccine maker PowderJect is now said to be in the latter
stages of takeover negotiations, with the interested party widely
tipped to be the USA's Chiron, rumoured to be proferring a bid
valuing the company at around...
Spotlight on the home of the celebrated pork pie in England, with
the annoucement this week that Melton Mowbray-based Bridgehead
Technologies and Pharmalicensing - two biopharmaceutical business
development companies - are to merge.
UK developer of medical diagnostics devices Osmetech continued the
strategy to build on its healthcare diagnostics business with the
acquisition this week of the Atlanta-based 'OPTI' product line of
blood gas analysers owned...
US company Molecular Devices, a supplier of bioanalytical
measurement systems, announced its revenues and earnings for the
quarter and year ended 31 December, 2002. Revenues for the fourth
quarter of 2002 were a healthy $30.2 million,...